Elsevier, a global information analytics business specialising in science and health, and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), have agreed to allow Elsevier to access NCATS’ rare disease database.
The Genetic and Rare Diseases Information Center (GARD), a program of NCATS, developed the database to provide patients, their families and friends, healthcare providers, and the public with current information on rare and/or genetic conditions and support sources.
Elsevier is building an online tool to help healthcare providers, particularly physicians, broaden the scope of diagnosis based not just on patients' symptom but also taking into consideration their medical history to predict a list of diseases to which the patient may be subject.
The GARD database will feed the Elsevier product’s content-based algorithm to predict a list of diseases based on the symptoms provided by the patient. Created in 2002, GARD is funded by two parts of the NIH: NCATS and the National Human Genome Research Institute (NHGRI). GARD provides the public with access to current, reliable and easy to understand information about rare or genetic diseases in English or Spanish.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
